The launch phase of a pharmaceutical drug is one of the most critical moments in its product life cycle. One drug typically takes 10-15 years of time and $2-3 billion of investment before it is approved by health authorities. With so much time and capital in the drug development process, companies have the critical mission of making a big impact at introduction while still ensuring long-term success of the drug.
A McKinsey study found that for 85% of pharmaceutical launches, the trajectory is set within the first 6 months of approval. Failure to address market dynamics and organizational challenges without the proper management structure, processes, and expertise in place, can lead to a sub-optimal trajectory.
CMK Select brings extensive product launch expertise and a proven methodology to fully optimize your next product launch. Our SELECT team of professionals come prepared to:
Build a commercialization plan and position a team of experts to maximize chances of optimal brand trajectory
Implement and manage the SELECT methodology that drives and monitors the entire launch process
Provide greater cost control and better risk anticipation/mitigation to brand teams by implementing best practices, tools, and KPIs to deliver more predictable launches